United Kingdom· GB-APID-21207111000001105
Signifor 0.3mg/1ml solution for injection ampoules
A pasireotide product containing pasireotide, registered in United Kingdom by Recordati Rare Diseases UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pasireotide is registered in 15 of 19 countries.
Countries holding a registration under ATC H01CB05 (pasireotide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Pasireotide · ATC H01CB05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pasireotide costs, country by country.
Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pasireotide · price per daily dose (1.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$238.10
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pasireotide
- Manufacturer
- Recordati Rare Diseases UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01CB05
- ATC class
- Pasireotide
- Defined daily dose
- 1.2 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5010678919158
- gtin5010678919257
- gtin3663502001158
- gtin3663502003695
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
435 interactions on record for pasireotide.
Graded by severity as the source publishes them — 246 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pasireotide · interactions on record
435 records
- 246 severe
- 184 moderate
- 5 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pasireotide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSIGNIFOR 0,3 MG SOLUCION INYECTABLERecordati Rare Diseases
- IcelandSigniforRecordati Rare Diseases*
- PolandSigniforRecordati Rare Diseases
- SwedenSignifor 0,3 mg Injektionsvätska, lösningRecordati Rare Diseases
- NetherlandsSignifor 0,3 mg oplossing voor injectieRecordati Rare Diseases
- CanadaSIGNIFORRECORDATI RARE DISEASES CANADA INC
- SwitzerlandSignifor 0.3 mg/1 ml, InjektionslösungRECORDATI AG
- IrelandSignifor 0.3 mg solution for injectionRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Signifor
- Liechtenstein · Signifor
- Norway · Signifor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e159b0e-44a2-4fa3-b0ed-130b48390f4b GET /v1/drugs/8e159b0e-44a2-4fa3-b0ed-130b48390f4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "21207111000001105",
"desc": "Signifor 0.3mg/1ml solution for injection ampoules (Recordati Rare Diseases UK Ltd)",
"form": "Solution for injection",
"vpid": "21216511000001101",
"source": "dmd",
"vtm_id": "777088009",
"strength": "300 microgram",
"substance": "Pasireotide",
"ingredient": "Pasireotide diaspartate",
"supplier_code": "3371801000001103"
}See everything about pasireotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.